Breaking News, Collaborations & Alliances

Körber Integrates PAS-X MES with Rommelag’s Pharmaceutical Filling Machines

Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X MES.

By: Rachel Klemovitch

Assistant Editor

Rommelag has achieved the “Ready” level certification in Körber’s PAS-X MSI Plug & Produce program. This certification confirms the compatibility of Rommelag’s aseptic filling machines with Körber’s PAS-X MES interface standards, enabling simplified, faster integration for pharmaceutical manufacturers.

This certification reinforces the value of standardized interfaces and interoperable ecosystems in creating customer-centric, future-ready production solutions.

With the PAS-X MSI Plug & Produce program, Körber’s Business Area Pharma offers a standardized approach to connect systems and equipment to its market-leading PAS-X MES. Rommelag’s newly certified “Ready” interface helps reduce custom engineering efforts and accelerates time-to-operation for customers looking to integrate Rommelag’s filling machines into digital manufacturing environments running PAS-X MES.

“Achieving the ‘Ready’ certification is a significant milestone in our digitalization journey. It confirms our commitment to seamlessly integrate our aseptic filling technology into PAS-X MES environments and demonstrates our commitment to open standards and customer-centric innovation. Together with Körber, we’re enabling pharmaceutical manufacturers to accelerate their digital transformation and reduce integration complexity – delivering real value from day one,” said Marcel Gehrlein, Managing Director at Rommelag Digital GmbH.

Lars Hornung, Senior Principal Alliances & Technology Partners Software at Körber Business Area Pharma, said, “At Körber, our goal is to minimize the complexity of system integration in our customers’ production environments. Within the Körber Ecosystem, we collaborate with partners like Rommelag to enable integration based on standard interfaces to accelerate projects.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters